Unveiling 4 Analyst Insights On Maravai LifeSciences
Unveiling 4 Analyst Insights On Maravai LifeSciences
揭示maravai lifesciences的四个分析师见解
During the last three months, 4 analysts shared their evaluations of Maravai LifeSciences (NASDAQ:MRVI), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，4位分析师分享了他们对Maravai LifeSciences（纳斯达克股票代码：MRVI）的评估，揭示了从看涨到看跌的不同前景。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Maravai LifeSciences, presenting an average target of $9.0, a high estimate of $11.00, and a low estimate of $7.00. Surpassing the previous average price target of $8.62, the current average has increased by 4.41%.
在评估12个月目标股价时，分析师公布了对Maravai LifeSciences的见解，将平均目标价定为9.0美元，最高估计为11.00美元，低估值为7.00美元。超过了之前的平均目标股价8.62美元，目前的平均价格上涨了4.41％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
The standing of Maravai LifeSciences among financial...
通过对近期分析...
登录免费看全文
登录/注册